Natural Product (NP) Details
| General Information of the NP (ID: NP3615) | |||||
|---|---|---|---|---|---|
| Name |
Piceatannol
|
||||
| Synonyms |
piceatannol; 10083-24-6; 3-Hydroxyresveratol; piceatanol; astringinin; 3,5,3',4'-Tetrahydroxystilbene; (E)-4-(3,5-dihydroxystyryl)benzene-1,2-diol; 3,3',4'5-Tetrahydroxystilbene; 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol; 3,3',4,5'-Tetrahydroxystilbene; UNII-6KS3LS0D4F; NSC 365798; NSC-365798; NSC 622471; 6KS3LS0D4F; CHEMBL69863; 3,3',4,5'-Stilbenetetrol; 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]benzene-1,2-diol; 4339-71-3; CHEBI:28814; C14H12O4; NSC365798; NSC622471; 1,2-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-
Click to Show/Hide
|
||||
| Species Origin | Rhodomyrtus tomentosa ... | Click to Show/Hide | |||
| Rhodomyrtus tomentosa | |||||
| Disease | Cytomegalovirus infection [ICD-11: 1A24] | Investigative | [1] | ||
| Structure |
|
Click to Download Mol2D MOL |
|||
| ADMET Property |
Absporption
Caco-2 Permeability
-5.029
MDCK Permeability
-4.797
PAMPA
- -
HIA
- - -
Distribution
VDss
-0.186
PPB
84.2%
BBB
- - -
Metabolism
CYP1A2 inhibitor
+++
CYP1A2 substrate
- - -
CYP2C19 inhibitor
- - -
CYP2C19 substrate
- - -
CYP2C9 inhibitor
- - -
CYP2C9 substrate
- - -
CYP2D6 inhibitor
- - -
CYP2D6 substrate
+++
CYP3A4 inhibitor
+++
CYP3A4 substrate
- - -
CYP2B6 inhibitor
- -
CYP2B6 substrate
- - -
CYP2C8 inhibitor
+++
HLM Stability
++
Excretion
CLplasma
12.586
T1/2
1.799
Toxicity
DILI
- -
Rat Oral Acute Toxicity
-
FDAMDD
++
Respiratory
-
Human Hepatotoxicity
+
Ototoxicity
-
Drug-induced Nephrotoxicity
- - -
Drug-induced Neurotoxicity
- - -
Hematotoxicity
- - -
Genotoxicity
+++
Tips: 1. For the classification endpoints, the prediction probability values are transformed into six symbols: 0-0.1 (- - -), 0.1-0.3 (- -), 0.3-0.5 (-), 0.5-0.7 (+), 0.7-0.9 (++), and 0.9-1.0 (+++).
2. Additionally, the corresponding relationships of the three labels are as follows: excellent; medium; poor.
Click to Show/Hide
|
||||
| Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
| Formula |
C14H12O4
|
||||
| PubChem CID | |||||
| Canonical SMILES |
C1=CC(=C(C=C1C=CC2=CC(=CC(=C2)O)O)O)O
|
||||
| InChI |
1S/C14H12O4/c15-11-5-10(6-12(16)8-11)2-1-9-3-4-13(17)14(18)7-9/h1-8,15-18H/b2-1+
|
||||
| InChIKey |
CDRPUGZCRXZLFL-OWOJBTEDSA-N
|
||||
| CAS Number |
CAS 10083-24-6
|
||||
| ChEBI ID | |||||
| Herb ID | |||||
| ETMC ID | |||||
| TTD Drug ID | |||||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
| Gemcitabine | Solid tumour/cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
| Augmenting Drug Sensitivity | Click to Show/Hide | |||||
| Representative Experiment Reporting the Effect of This Combination | [2] | |||||
| Detail(s) |
Combination Info
click to show the detail info of this combination
|
|||||
| Molecule(s)
Regulation |
Up-regulation | Expression | BAK | Molecule Info |
Pathway MAP
|
|
| In-vitro Model | A-549 | CVCL_0023 | Lung adenocarcinoma | Homo sapiens | ||
| Experimental
Result(s) |
Piceatannol can enhance the cytotoxic effects of gemcitabine by enhancing expression of the proapoptotic protein Bak. | |||||
| Target and Pathway | ||||
|---|---|---|---|---|
| Target(s) | Interferon regulatory factor 3 (IRF3) | Molecule Info | [3] | |
| KEGG Pathway | Toll-like receptor signaling pathway | Click to Show/Hide | ||
| 2 | RIG-I-like receptor signaling pathway | |||
| 3 | Cytosolic DNA-sensing pathway | |||
| 4 | Pertussis | |||
| 5 | Hepatitis C | |||
| 6 | Hepatitis B | |||
| 7 | Measles | |||
| 8 | Influenza A | |||
| 9 | Herpes simplex infection | |||
| 10 | Epstein-Barr virus infection | |||
| 11 | Viral carcinogenesis | |||
| Panther Pathway | Toll receptor signaling pathway | Click to Show/Hide | ||
| Reactome | ISG15 antiviral mechanism | Click to Show/Hide | ||
| 2 | LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | |||
| 3 | Interferon gamma signaling | |||
| 4 | Interferon alpha/beta signaling | |||
| 5 | TRAF3-dependent IRF activation pathway | |||
| 6 | TRAF6 mediated IRF7 activation | |||
| 7 | Negative regulators of RIG-I/MDA5 signaling | |||
| 8 | Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | |||
| 9 | Factors involved in megakaryocyte development and platelet production | |||
| WikiPathways | Toll-like receptor signaling pathway | Click to Show/Hide | ||
| 2 | Cytosolic sensors of pathogen-associated DNA | |||
| 3 | MyD88-independent cascade | |||
| 4 | ISG15 antiviral mechanism | |||
| 5 | Apoptosis | |||
| 6 | RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways | |||
| 7 | Factors involved in megakaryocyte development and platelet production | |||
| 8 | Regulation of toll-like receptor signaling pathway | |||